{
  "trial_id": "NCT01839721",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "pelvic cancer",
      "label": "met",
      "evidence": "gynecologic, rectal, or prostatic"
    },
    {
      "criterion": "radiotherapy treatments for a minimum of 40 Gy at the pelvic level",
      "label": "met",
      "evidence": "with or without chemotherapy"
    },
    {
      "criterion": "Eastern Cooperative Oncology Group(ECOG) performance status of 0 or 1",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "previous radiotherapy treatments in the pelvic or abdominal region",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "medical history of gastro-intestinal inflammation, malabsorption syndrome or inflammatory bowel disease or coeliac disease",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "ileostomy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "daily use of anti-diarrheal medication before radiotherapy",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "pregnancy or breastfeeding",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "neutropenia or probiotics intolerance",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "6",
    "trial_id": "NCT01839721",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}